Nanjing Hicin Pharmaceutical Co Ltd
Nanjing Hicin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of chemical preparations, APIs, and intermediates. The company's products include landiolol hydrochloride, rivaroxaban, tigecycline, torasemide, cefuroxime sodium, ceftriaxone hydrochloride, ganciclovir sodium, adenosine monophosphate, and adenosine monophosphate for … Read more
Nanjing Hicin Pharmaceutical Co Ltd (300584) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.007x
Based on the latest financial reports, Nanjing Hicin Pharmaceutical Co Ltd (300584) has a cash flow conversion efficiency ratio of -0.007x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-7.15 Million) by net assets (CN¥1.07 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nanjing Hicin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Nanjing Hicin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nanjing Hicin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nanjing Hicin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chengdu Huasun Group Inc Ltd
SHE:000790
|
-0.142x |
|
engcon AB Cl B
ST:ENGCON-B
|
0.063x |
|
MGP Ingredients Inc
NASDAQ:MGPI
|
0.041x |
|
Hangzhou Heshun Technology Co.LTD.
SHE:301237
|
N/A |
|
Shaanxi Kanghui Pharm Co Ltd
SHG:603139
|
0.010x |
|
Orange Belgium SA
BR:OBEL
|
0.130x |
|
Ningbo Haitian Precision Machinery Co Ltd
SHG:601882
|
0.053x |
|
Joeone Co Ltd
SHG:601566
|
0.013x |
Annual Cash Flow Conversion Efficiency for Nanjing Hicin Pharmaceutical Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Nanjing Hicin Pharmaceutical Co Ltd from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.04 Billion | CN¥59.96 Million | 0.058x | +138.31% |
| 2023-12-31 | CN¥987.50 Million | CN¥23.93 Million | 0.024x | +495.88% |
| 2022-12-31 | CN¥950.57 Million | CN¥-5.82 Million | -0.006x | -109.69% |
| 2021-12-31 | CN¥948.48 Million | CN¥59.94 Million | 0.063x | -41.53% |
| 2020-12-31 | CN¥678.97 Million | CN¥73.39 Million | 0.108x | -27.33% |
| 2019-12-31 | CN¥653.98 Million | CN¥97.28 Million | 0.149x | +11.91% |
| 2018-12-31 | CN¥580.93 Million | CN¥77.21 Million | 0.133x | +47.79% |
| 2017-12-31 | CN¥517.68 Million | CN¥46.56 Million | 0.090x | -34.20% |
| 2016-12-31 | CN¥276.11 Million | CN¥37.74 Million | 0.137x | -40.39% |
| 2015-12-31 | CN¥235.08 Million | CN¥53.90 Million | 0.229x | +88.91% |
| 2014-12-31 | CN¥200.15 Million | CN¥24.29 Million | 0.121x | -55.41% |
| 2013-12-31 | CN¥165.93 Million | CN¥45.16 Million | 0.272x | -6.87% |
| 2012-12-31 | CN¥132.65 Million | CN¥38.77 Million | 0.292x | -- |